Term
|
Definition
| Stigma is pressure from society to make us live in a particular way. |
|
|
Term
| What is the most common symptom of all STIs? |
|
Definition
| The most common symptom of STIs are none at all. |
|
|
Term
|
Definition
| Discharge, burning sensation when urinating - May cause PID |
|
|
Term
|
Definition
| Fever, swollen lymph glands, sore throat, patchy hair loss, headaches, weight loss, muscle aches, and fatigue |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| White/yellow/green discharge (women will have no symptoms) |
|
|
Term
|
Definition
| Intentionally revealing info about yourself that cannot be observed by others |
|
|
Term
| Why don’t people disclose important sexual information? |
|
Definition
| People dont disclose because it involves risk and vulnerability on the part of the person. |
|
|
Term
| What are the most commonly treated STIs? |
|
Definition
| Women = Trichomoniasis, Chlamydia = most reported STD, Common STD = Herpes |
|
|
Term
| How is Trichomoniasis treated? |
|
Definition
|
|
Term
| How is Chlamydia treated? |
|
Definition
|
|
Term
|
Definition
|
|
Term
| What are the female implications of leaving certain STIs untreated? |
|
Definition
|
|
Term
| Which vaccine was used as a vector in the Merck Trial? |
|
Definition
| The Merck Trial used a adenovirus vector. |
|
|
Term
| What does HEPS stand for? |
|
Definition
| HEPS stands for Highly-Exposed Persistently Seronegative |
|
|
Term
|
Definition
| SAM is the sympathetic adrenal-medullary system (flight or fight response) which when activated can enhance the immune system. |
|
|
Term
|
Definition
| HPAC is the hypothalamic-pituitary-adrenocorticial system (distress system) which will suppress immune system when activate. |
|
|
Term
| Part B of the Ryan White Act.... |
|
Definition
| AIDS Drug Assistance Program (ADAP), helps people afford their medications. |
|
|
Term
| Part A of the Ryan White Act... |
|
Definition
| Continued care for people living with HIV. Provides core medical and support services. |
|
|
Term
| Part C of the Ryan White Act... |
|
Definition
| Provides outpatient HIV early intervention services and ambulatory care (MIHS) |
|
|
Term
| Part D of the Ryan White Act... |
|
Definition
| Provides family-centered care for infants, children, and youth. Primary care. |
|
|
Term
|
Definition
| Maricopa Integrated Health System |
|
|
Term
| Pure Food and Drugs Act - 1906 |
|
Definition
Inspired by Upton Sinclair’s The Jungle
Required manufacturers to declare drug contents (only) |
|
|
Term
| Food Drug and Cosmetic Act - 1938 |
|
Definition
| Required drugs to be proven safe...but not necessarily effectiveness. |
|
|
Term
| Durham-Humphrey Amendment (To Food, Drug and Cosmetic Act)-1951 |
|
Definition
| Required certain drugs to be available only by prescription |
|
|
Term
| Kefauver-Harris Act - 1962 |
|
Definition
| Required drug efficacy in order to be put on market. |
|
|
Term
| Arizona HIV/AIDS stats in Children |
|
Definition
-69 infected children
-196 exposed infants
-Following 261 children total |
|
|
Term
| Presenting signs/symptoms among youth with HIV infection |
|
Definition
| Lack of growth, Fatigue, no achievement of normal development (crawling walking talking sitting), LIP- lymphoid interstitial pneumonia, Teen Pregnancy(?what?), acute sever illness with no clear cause |
|
|
Term
| What is a proximal cause of the HIV/AIDS epidemic? |
|
Definition
|
|
Term
| What is a distal cause of the HIV epidemic? |
|
Definition
|
|
Term
|
Definition
| Founded Body Positive, Restarted AIDS walk |
|
|
Term
|
Definition
| Transmission Related Acute Lung Injury, comes from donated plasma from women who have given birth (causes lungs to fill with liquid destroying the lung- antigen related) |
|
|
Term
| Phase I of Clinical Trials |
|
Definition
| Healthy humans, used to study safety, and maximum safe dose |
|
|
Term
| Phase II of Clinical Trials |
|
Definition
| Used to determine efficacy, effective dose, delivery method, etc. |
|
|
Term
| Phase III of Clinical Trials... |
|
Definition
|
|
Term
| Phase IV of clinical trials... |
|
Definition
| Measuring long term effects after drug is approved |
|
|
